ANDA 76327, held by Sun Pharm Inds Ltd. Topiramate.
As of Nov 15, 2026, ANDA 76327 (Topiramate), held by Sun Pharm Inds Ltd, was first approved by FDA on Mar 27, 2009, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 27, 2009 | Original application | Approved | None posted |
| Topiramate25MG · tablet;oral | Topiramate | Discontinued |
| Topiramate100MG · tablet;oral | Topiramate | Discontinued |
| Topiramate200MG · tablet;oral | Topiramate | Discontinued |
| Feb 23, 2026 | Supplement 14Labeling · Standard review | Approved | None posted |
| Feb 23, 2026 | Supplement 13Labeling · Standard review | Approved | None posted |
| Feb 23, 2026 | Supplement 12Labeling · Standard review | Approved | None posted |
| Feb 23, 2026 | Supplement 11Labeling · Standard review | Approved | None posted |
| Feb 23, 2026 | Supplement 10Labeling · Standard review | Approved | None posted |
| Feb 23, 2026 | Supplement 9Labeling · Standard review | Approved | None posted |
| Feb 23, 2026 | Supplement 8Labeling · Standard review | Approved | None posted |
| Feb 23, 2026 | Supplement 7Labeling · Standard review | Approved | None posted |
| May 21, 2018 | Supplement 6Labeling · Standard review | Approved | None posted |
| May 21, 2018 | Supplement 5Labeling · Standard review | Approved | None posted |
| May 21, 2018 | Supplement 4Labeling · Standard review | Approved | None posted |
| Nov 17, 2014 | Supplement 3Labeling · Standard review | Approved | None posted |
| Nov 17, 2014 | Supplement 1Labeling | Approved | None posted |
| Mar 27, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters